Stealth BioTherapeutics (Stealth BioTherapeutics) FCF Margin % : 0.00% (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stealth BioTherapeutics's Free Cash Flow for the three months ended in Mar. 2022 was $0.00 Mil. Stealth BioTherapeutics's Revenue for the three months ended in Mar. 2022 was $0.00 Mil. Therefore, Stealth BioTherapeutics's FCF Margin % for the quarter that ended in Mar. 2022 was 0.00%.

As of today, Stealth BioTherapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Stealth BioTherapeutics's FCF Margin % or its related term are showing as below:

MITO's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -144.01
* Ranked among companies with meaningful FCF Margin % only.

Stealth BioTherapeutics FCF Margin % Historical Data

The historical data trend for Stealth BioTherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics FCF Margin % Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

FCF Margin %

Get a 7-Day Free Trial

-228.17

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Stealth BioTherapeutics's FCF Margin %

For the Biotechnology subindustry, Stealth BioTherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stealth BioTherapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's FCF Margin % falls into.

Stealth BioTherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Stealth BioTherapeutics's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-45.038	/	0
	=	%

Stealth BioTherapeutics's FCF Margin for the quarter that ended in Mar. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2022 )	/	Revenue (Q: Mar. 2022 )
	=	0	/	0
	=	%

Stealth BioTherapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.